Northwest Biotherapeutics reported $445K in Sales Revenues for its fiscal quarter ending in December of 2023.





Sales Change Date
Agenus USD 24.07M 2.77M Mar/2025
AstraZeneca USD 15.5B 313M Dec/2025
Bristol-Myers Squibb USD 12.5B 300M Dec/2025
Celldex Therapeutics USD 890K 160K Sep/2025
Eisai JPY 219.94B 22.58B Dec/2025
Infinity Pharmaceuticals USD 583K 148K Jun/2023
Merck USD 16.4B 880M Dec/2025
Northwest Biotherapeutics USD 445K 39K Dec/2023
Pfizer USD 17.58B 880M Dec/2025
Plus Therapeutics USD 1.31M 73K Dec/2023
Roche Holding CHF 15.65B 274.5M Dec/2025